O uso do cortisol salivar no teste da desmopressina na doença de Cushing e na obesidade

Detalhes bibliográficos
Autor(a) principal: Ricardo Mundim Firme
Data de Publicação: 2017
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UFMG
Texto Completo: http://hdl.handle.net/1843/BUOS-B44JS5
Resumo: Cushing's disease is still an important diagnostic and therapeutic challenge, as well as showing very high morbidity and mortality. Primary obesity, a worldwide epidemic, is increasingly present in this arduous differential diagnosis. The classic desmopressin test, with serum cortisol and ACTH measurements after venous administration of 10mcg of desmopressin, has been shown to have excellent accuracy in the context of exclusion of Cushing's syndrome in patients with nontumoral hypercortisolism; this occurs with a quality equal to or greater than the synthetic corticotrophin (CRH) test. Salivary cortisol was added to the classic test, and 19 individuals from specific outpatient clinics of the UFMG medical school were added to the test: 11 patients with active Cushing's disease (group A) and 08 individuals with moderate to severe obesity (BMI greater than 35kg / m2 - group B). All patients in the first group were submitted to current criteria of hypercortisolism activity and obese patients were excluded from this initial laboratory change. The groups were clinically homogeneous, but with an important difference in descriptive parameters and statistical tests. Significant differences were observed in intragroup analyzes (Anova Two way multiple analyzes, p <0.05) and intergroup (p <0.01); it was observed that in group A an increase of salivary cortisol in relation to basal (increases of 66 to 309%), and a strong positive correlation between salivary cortisol and serum cortisol in some (45, 60,120 minutes) in Cushing disease group. The addition of salivary cortisol to the dynamic test is well indicated in the current context of neuroendocrinology, may after future analysis add diagnostic accuracy and even simplify the dynamic test. A larger, more diverse and multicentric population should be analyzed and more robust data obtained.
id UFMG_2b59583459e2701f6e9f52a164b12181
oai_identifier_str oai:repositorio.ufmg.br:1843/BUOS-B44JS5
network_acronym_str UFMG
network_name_str Repositório Institucional da UFMG
repository_id_str
spelling O uso do cortisol salivar no teste da desmopressina na doença de Cushing e na obesidadeTeste da DesmopressinaCortisol SalivarSíndrome de CushingObesidadeDoença de CushingDesamino arginina vasopressinaHidrocortisonaSíndrome de CushingMedicinaCushing's disease is still an important diagnostic and therapeutic challenge, as well as showing very high morbidity and mortality. Primary obesity, a worldwide epidemic, is increasingly present in this arduous differential diagnosis. The classic desmopressin test, with serum cortisol and ACTH measurements after venous administration of 10mcg of desmopressin, has been shown to have excellent accuracy in the context of exclusion of Cushing's syndrome in patients with nontumoral hypercortisolism; this occurs with a quality equal to or greater than the synthetic corticotrophin (CRH) test. Salivary cortisol was added to the classic test, and 19 individuals from specific outpatient clinics of the UFMG medical school were added to the test: 11 patients with active Cushing's disease (group A) and 08 individuals with moderate to severe obesity (BMI greater than 35kg / m2 - group B). All patients in the first group were submitted to current criteria of hypercortisolism activity and obese patients were excluded from this initial laboratory change. The groups were clinically homogeneous, but with an important difference in descriptive parameters and statistical tests. Significant differences were observed in intragroup analyzes (Anova Two way multiple analyzes, p <0.05) and intergroup (p <0.01); it was observed that in group A an increase of salivary cortisol in relation to basal (increases of 66 to 309%), and a strong positive correlation between salivary cortisol and serum cortisol in some (45, 60,120 minutes) in Cushing disease group. The addition of salivary cortisol to the dynamic test is well indicated in the current context of neuroendocrinology, may after future analysis add diagnostic accuracy and even simplify the dynamic test. A larger, more diverse and multicentric population should be analyzed and more robust data obtained.A doença de Cushing continua sendo, ainda nos dias atuais, importante desafio diagnóstico e terapêutico, além de implicar altíssima morbimortalidade. A obesidade primária, uma epidemia mundial, está cada vez mais presente nesse árduo diagnóstico diferencial. O teste da desmopressina clássico, com medidas do cortisol e hormônio adrenocorticotrófico (ACTH) séricos após administração venosa de 10 mcg de desmopressina, tem mostrado ótima acurácia no contexto da exclusão da síndrome de Cushing em pacientes portadores de hipercortisolismo não tumoral. Isso ocorre com qualidade igual ou superior ao teste do corticotrofina (CRH) sintética. Foi adicionado o cortisol salivar ao teste clássico, ao qual foram submetidos 19 indivíduos de ambulatórios específicos da Escola de medicina da Universidade Federal de Minas Gerais (UFMG), sendo 11 pacientes com doença de Cushing em atividade (grupo A) e oito portadores de obesidade moderada a grave (IMC > 35 kg/m2 grupo B). Todos os pacientes do primeiro grupo foram submetidos a critérios atuais de atividade do hipercortisolismo e os obesos tiveram excluída essa alteração laboratorial inicialmente. Os grupos mostraram-se homogêneos clinicamente, mas com importante diferença nos paramentos descritivos e nos testes estatísticos. Observaram-se significativas diferenças nas análises intragrupo (Anova two way análises múltiplas, p<0,05) e intergrupos (p<0,01). Nos portadores de hipercortisolismo ocorreu um aumento do cortisol salivar em relação ao basal (aumentos de 66 a 309%) e uma correlação positiva (p<0,05) entre o cortisol salivar e o cortisol sérico em alguns tempos do teste (45, 60, 120 minutos) no grupo A. O acréscimo do cortisol salivar ao teste dinâmico encontra-se bem indicado no contexto atual da neuroendocrinologia e pode, após análises futuras, adicionar acurácia diagnóstica e mesmo simplificar o teste dinâmico. Deve-se analisar uma população maior, mais diversificada e multicêntrica para se obter dados mais robustos.Universidade Federal de Minas GeraisUFMGAntonio Ribeiro de Oliveira JuniorBeatriz Santana Soares RochaPaulo Augusto Carvalho MirandaRicardo Mundim Firme2019-08-09T22:41:26Z2019-08-09T22:41:26Z2017-09-27info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/1843/BUOS-B44JS5info:eu-repo/semantics/openAccessporreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMG2019-11-14T10:03:19Zoai:repositorio.ufmg.br:1843/BUOS-B44JS5Repositório InstitucionalPUBhttps://repositorio.ufmg.br/oairepositorio@ufmg.bropendoar:2019-11-14T10:03:19Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false
dc.title.none.fl_str_mv O uso do cortisol salivar no teste da desmopressina na doença de Cushing e na obesidade
title O uso do cortisol salivar no teste da desmopressina na doença de Cushing e na obesidade
spellingShingle O uso do cortisol salivar no teste da desmopressina na doença de Cushing e na obesidade
Ricardo Mundim Firme
Teste da Desmopressina
Cortisol Salivar
Síndrome de Cushing
Obesidade
Doença de Cushing
Desamino arginina vasopressina
Hidrocortisona
Síndrome de Cushing
Medicina
title_short O uso do cortisol salivar no teste da desmopressina na doença de Cushing e na obesidade
title_full O uso do cortisol salivar no teste da desmopressina na doença de Cushing e na obesidade
title_fullStr O uso do cortisol salivar no teste da desmopressina na doença de Cushing e na obesidade
title_full_unstemmed O uso do cortisol salivar no teste da desmopressina na doença de Cushing e na obesidade
title_sort O uso do cortisol salivar no teste da desmopressina na doença de Cushing e na obesidade
author Ricardo Mundim Firme
author_facet Ricardo Mundim Firme
author_role author
dc.contributor.none.fl_str_mv Antonio Ribeiro de Oliveira Junior
Beatriz Santana Soares Rocha
Paulo Augusto Carvalho Miranda
dc.contributor.author.fl_str_mv Ricardo Mundim Firme
dc.subject.por.fl_str_mv Teste da Desmopressina
Cortisol Salivar
Síndrome de Cushing
Obesidade
Doença de Cushing
Desamino arginina vasopressina
Hidrocortisona
Síndrome de Cushing
Medicina
topic Teste da Desmopressina
Cortisol Salivar
Síndrome de Cushing
Obesidade
Doença de Cushing
Desamino arginina vasopressina
Hidrocortisona
Síndrome de Cushing
Medicina
description Cushing's disease is still an important diagnostic and therapeutic challenge, as well as showing very high morbidity and mortality. Primary obesity, a worldwide epidemic, is increasingly present in this arduous differential diagnosis. The classic desmopressin test, with serum cortisol and ACTH measurements after venous administration of 10mcg of desmopressin, has been shown to have excellent accuracy in the context of exclusion of Cushing's syndrome in patients with nontumoral hypercortisolism; this occurs with a quality equal to or greater than the synthetic corticotrophin (CRH) test. Salivary cortisol was added to the classic test, and 19 individuals from specific outpatient clinics of the UFMG medical school were added to the test: 11 patients with active Cushing's disease (group A) and 08 individuals with moderate to severe obesity (BMI greater than 35kg / m2 - group B). All patients in the first group were submitted to current criteria of hypercortisolism activity and obese patients were excluded from this initial laboratory change. The groups were clinically homogeneous, but with an important difference in descriptive parameters and statistical tests. Significant differences were observed in intragroup analyzes (Anova Two way multiple analyzes, p <0.05) and intergroup (p <0.01); it was observed that in group A an increase of salivary cortisol in relation to basal (increases of 66 to 309%), and a strong positive correlation between salivary cortisol and serum cortisol in some (45, 60,120 minutes) in Cushing disease group. The addition of salivary cortisol to the dynamic test is well indicated in the current context of neuroendocrinology, may after future analysis add diagnostic accuracy and even simplify the dynamic test. A larger, more diverse and multicentric population should be analyzed and more robust data obtained.
publishDate 2017
dc.date.none.fl_str_mv 2017-09-27
2019-08-09T22:41:26Z
2019-08-09T22:41:26Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1843/BUOS-B44JS5
url http://hdl.handle.net/1843/BUOS-B44JS5
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Minas Gerais
UFMG
publisher.none.fl_str_mv Universidade Federal de Minas Gerais
UFMG
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFMG
instname:Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
instname_str Universidade Federal de Minas Gerais (UFMG)
instacron_str UFMG
institution UFMG
reponame_str Repositório Institucional da UFMG
collection Repositório Institucional da UFMG
repository.name.fl_str_mv Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)
repository.mail.fl_str_mv repositorio@ufmg.br
_version_ 1816829749157167104